NCT04012229View on ClinicalTrials.gov

IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)

CompletedOBSERVATIONAL
Enrollment

2,295

Participants

Timeline

Start Date

July 28, 2017

Primary Completion Date

June 21, 2018

Study Completion Date

June 21, 2018

Conditions
Breast CancerBRCA1 MutationBRCA2 Mutation
Interventions
GENETIC

BRCA mutation

The genetic testing was performed according interregional consensus (Manchester score \> or = 16) on blood sample using classical chain-termination (Sanger sequencing) and multiplex ligation-dependant probe amplification to search large rearrangements.

Trial Locations (1)

25030

University Hospital Jean Minjoz, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT04012229 - IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA) | Biotech Hunter | Biotech Hunter